Industries We
Serve

Serving industries that rely on biological and genetic resources, enabling responsible innovation and commiteed for nature-positive supply chains.

Built for Industry Decision Makers

Enabling informed industry decisions by reducing uncertainty in genetic resource access while ensuring conservation and sustainable use. NatureXchange supports businesses in managing this uncertainty, addressing nature-related risks in genetic resource supply chains, and enabling in-situ conservation in alignment with Nagoya Protocol requirements.

Sectors We Work With

Life Science Manufacturers

Integrating Compliance into Production

Manufacturers in pharmaceuticals, nutraceuticals, cosmetics, and biotech depend on biological resources for innovation.

We help production-driven businesses:

Ingredient Suppliers

Securing Supply Chains with Legal Integrity

Ingredient suppliers operate at the foundation of the value chain. Any compliance gap can disrupt entire production ecosystems.

We support suppliers with:

Botanical Extract Companies

From Biodiversity to Market  Responsibly

Botanical companies rely heavily on genetic resources and traditional knowledge.

We assist with:

R&D-Driven Startups

Innovate Without Future Liability

Early-stage biotech and life-science startups often prioritize innovation speed but early compliance decisions shape long-term scalability.

We help startups:

IP-Driven Growth Companies

Protecting Innovation in a Disclosure Era

Patent systems increasingly require ABS disclosure and proof of lawful access.

We provide:

Our Approach to Industry Partnerships

Our approach is built around three strategic pillars:

Regulatory Clarity

Understanding biodiversity laws and regulatory frameworks.

Strategic Structuring

Designing compliant sourcing and benefit sharing models.

Commercial Alignment

Ensuring compliance supports innovation, investment, and global market access.

Regulatory Reality These Industries Face

Across industries, companies face challenges such as:

Let’s Build a Legally Secure Growth Framework

If your business depends on biological resources, structured ABS strategy is no longer optional.

Frequently Asked Questions

The Nagoya Protocol directly impacts companies using biological or genetic resources by imposing legal obligations on access, use, and benefit-sharing. Non-compliance can result in fines, loss of IP rights, and restricted market access.

Pharmaceuticals, biotechnology, agriculture, cosmetics, nutraceuticals, and any sector relying on natural ingredients or genetic material.

R&D on biological materials, product development using natural ingredients, commercialization of bio-based products, and use of traditional knowledge.

R&D on biological materials, product development using natural ingredients, commercialization of bio-based products, and use of traditional knowledge.

Legally binding agreements defining how benefits (royalties, milestones, tech transfer) are shared between companies and provider countries.

The ABS Clearing-House is a global database providing verified information on national ABS rules, permits, and compliance requirements. Companies use it to conduct due diligence and reduce legal risks.

Join the Ecosystem

Partner with us to build nature-positive supply chains through responsible genetic resource use, driving biodiversity conservation and enabling compliant, transparent sourcing.